MedTrace Logo

Can Myotonometry Quantify Dry Needling Effectiveness on Myofascial Trigger Points?

NCT02952053 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2023-05-12

No results posted yet for this study

Summary

The main objective of this study is to assess effects of Dry Needling into Myofascial Trigger Point compared Dry Needling into Taut Band point based on the outcomes of myotnometric measurement in healthy subjects.

Hypothesis: Deep Dry Needling of the latent medial Myofascial Trigger Point (MTrP) of the soleus muscle will achieve changes in myotonometric measures compared to Deep Dry Needling of the Taut Band of the soleus muscle.

Conditions

  • Muscle Tone Abnormalities

Interventions

DEVICE

MTrP Group

Deep Dry Needling into the site of the latent medial Myofascial Trigger Point of the soleus muscle. 1 session in soleus muscle. 10 fast in and fast out needle insertions.

DEVICE

TB Group

Deep Dry Needling distal to Myofascial Trigger Point but into the same taut band. 1 session in soleus muscle. 10 fast in and fast out needle insertions.

Sponsors & Collaborators

  • Hospital Nacional de Parapléjicos de Toledo

    collaborator OTHER

  • Universidad San Jorge

    collaborator OTHER

  • University of Castilla-La Mancha

    lead OTHER

Principal Investigators

  • Julio Gomez Soriano, PhD · University of Castilla-La Mancha

  • María Ortiz Lucas, PhD · Universidad San Jorge

  • Carolina Jiménez Sánchez, MSc · Universidad San Jorge

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-12-12
Primary Completion
2017-07-01
Completion
2017-07-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02952053 on ClinicalTrials.gov